Propel Bio Management »

Vanguard Short-Term Bond ETF shares owned by Propel Bio Management

Quarter-by-quarter ownership of Vanguard Short-Term Bond ETF (BSV) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Vanguard Short-Term Bond ETF

Tip: Access up to 7 years of quarterly data

All positions including Vanguard Short-Term Bond ETF held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanguard Short-Term Bond ETF by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 28k 77.02

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Vanguard Short-Term Bond ETF

Goldman Sachs Group
Mercer Global Advisors
Jpmorgan Chase & Co
Empower Advisory Group
Hanson McClain Advisors
Bank of America Corporation
Wells Fargo & Company
Truepoint
United Capital Financial Advisers
H D Vest Advisory Services
Envestnet Portfolio Solutions
Royal Bank of Canada
CI Private Wealth
Lincoln National
Charles Schwab Investment Management

View all funds holding Vanguard Short-Term Bond ETF